Overview

Safety and Pharmacokinetic Profile of Udenafil in Healthy Mexican Adults

Status:
Completed
Trial end date:
2013-08-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the safety and tolerability of Udenafil 150 mg compared to placebo.
Phase:
Phase 1
Details
Lead Sponsor:
Takeda
Treatments:
Udenafil